Idarubicin Hydrochloride (Teva Parenteral Medicines, Inc.)


Welcome to the PulseAid listing for the Idarubicin Hydrochloride drug offered from Teva Parenteral Medicines, Inc.. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Parenteral Medicines, Inc.
NON-PROPRIETARY NAME: Idarubicin Hydrochloride
SUBSTANCE NAME: IDARUBICIN HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2002-10-01
END MARKETING DATE: 0000-00-00


Idarubicin Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIdarubicin Hydrochloride from Teva Parenteral Medicines, Inc.
LABELER NAME: Teva Parenteral Medicines, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2002-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0703-4154_903278ff-4613-4b29-9b22-97bbe312ecbd
PRODUCT NDC: 0703-4154
APPLICATION NUMBER: ANDA065036

Other IDARUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amneal-Agila, LLCIdarubicin Hydrochloride
Fresenius Kabi USA, LLCIdarubicin Hydrochloride
Pharmacia and Upjohn Company LLCIdamycin PFS
Sandoz IncIdarubicin Hydrochloride
Teva Parenteral Medicines, Inc.Idarubicin Hydrochloride
West-Ward Pharmaceuticals CorpIdarubicin Hydrochloride